Miriam Bollmann

454 total citations
21 papers, 329 citations indexed

About

Miriam Bollmann is a scholar working on Rheumatology, Molecular Biology and Cell Biology. According to data from OpenAlex, Miriam Bollmann has authored 21 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Miriam Bollmann's work include Osteoarthritis Treatment and Mechanisms (9 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Miriam Bollmann is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (9 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Protease and Inhibitor Mechanisms (3 papers). Miriam Bollmann collaborates with scholars based in Germany, Sweden and United Kingdom. Miriam Bollmann's co-authors include Jessica Bertrand, Thomas Pap, Christoph H. Lohmann, Slavko Gašparov, Anja von Heydebreck, Claus Langer, Hans-Juergen Schulten, L. Füzesi, Bjoern Sander and Florian Haller and has published in prestigious journals such as ACS Nano, British Journal of Pharmacology and Annals of the Rheumatic Diseases.

In The Last Decade

Miriam Bollmann

20 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Bollmann Germany 8 116 111 66 61 58 21 329
Jiro Ogino Japan 12 85 0.7× 80 0.7× 165 2.5× 26 0.4× 63 1.1× 27 398
Guanyu Yu China 13 87 0.8× 35 0.3× 110 1.7× 63 1.0× 9 0.2× 43 456
Yong Il Kim South Korea 7 39 0.3× 98 0.9× 111 1.7× 46 0.8× 24 0.4× 21 448
Yoshiko Tamai Japan 11 94 0.8× 34 0.3× 53 0.8× 23 0.4× 229 3.9× 40 534
Şirin Başpınar Türkiye 12 102 0.9× 17 0.2× 80 1.2× 32 0.5× 11 0.2× 33 350
Rabia Islam Pakistan 13 203 1.8× 39 0.4× 13 0.2× 20 0.3× 12 0.2× 33 364
Mai Iwaya Japan 10 62 0.5× 39 0.4× 81 1.2× 14 0.2× 12 0.2× 65 313
Ryosuke Ikeda Japan 16 158 1.4× 32 0.3× 315 4.8× 122 2.0× 94 1.6× 64 714
Wioleta Marut Netherlands 13 107 0.9× 52 0.5× 64 1.0× 5 0.1× 17 0.3× 17 420
Emi Nishimagi Japan 8 88 0.8× 49 0.4× 48 0.7× 18 0.3× 15 0.3× 13 360

Countries citing papers authored by Miriam Bollmann

Since Specialization
Citations

This map shows the geographic impact of Miriam Bollmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Bollmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Bollmann more than expected).

Fields of papers citing papers by Miriam Bollmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Bollmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Bollmann. The network helps show where Miriam Bollmann may publish in the future.

Co-authorship network of co-authors of Miriam Bollmann

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Bollmann. A scholar is included among the top collaborators of Miriam Bollmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Bollmann. Miriam Bollmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bollmann, Miriam, Yvonne Garbers, Eugen Feist, et al.. (2025). Transforming growth factor beta induces interleukin-11 expression in osteoarthritis. Cytokine. 187. 156863–156863. 1 indexed citations
2.
Hu, Zhicheng, Anders Jarneborn, Miriam Bollmann, et al.. (2025). Combination treatment with anti-RANKL and antibiotics for preventing joint destruction in septic arthritis. JCI Insight. 10(6). 1 indexed citations
3.
4.
Bertrand, Jessica, Jayashree Sahana, Miriam Bollmann, et al.. (2023). Structural and Molecular Changes of Human Chondrocytes Exposed to the Rotating Wall Vessel Bioreactor. Biomolecules. 14(1). 25–25. 2 indexed citations
5.
McBride, David A., M. Kerr, Miriam Bollmann, et al.. (2023). Immunomodulatory Nanoparticles for Modulating Arthritis Flares. ACS Nano. 18(3). 1892–1906. 7 indexed citations
6.
Bollmann, Miriam, et al.. (2021). The role of calcium crystals and their effect on osteoarthritis pathogenesis. Best Practice & Research Clinical Rheumatology. 35(4). 101722–101722. 20 indexed citations
7.
Bollmann, Miriam, Dirk Bartel, Christoph H. Lohmann, et al.. (2021). Synthesis of a Lubricant to Mimic the Biorheological Behavior of Osteoarthritic and Revision Synovial Fluid. Lubricants. 9(9). 87–87. 3 indexed citations
8.
Bertrand, Jessica, J. Sherwood, Frank Rutsch, et al.. (2020). BCP crystals promote chondrocyte hypertrophic differentiation in OA cartilage by sequestering Wnt3a. Annals of the Rheumatic Diseases. 79(7). 975–984. 38 indexed citations
9.
Bollmann, Miriam, Adelheid Korb‐Pap, Ulrich König, et al.. (2020). Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling. Annals of the Rheumatic Diseases. 79(4). 481–489. 20 indexed citations
10.
Bollmann, Miriam, Aare Märtson, Thomas Pap, et al.. (2020). MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity. Osteoarthritis and Cartilage. 29(2). 280–289. 41 indexed citations
11.
Meyer, François G., Miriam Bollmann, Uwe Kornak, & Jessica Bertrand. (2020). AB0067 CHONDROCALCINOSIS IS ASSOCIATED WITH A SPECIFIC EFFECT ON THE CHONDROCYTE PHENOTYPE THAT MARKEDLY DIFFERS FROM OA. Annals of the Rheumatic Diseases. 79. 1334–1334. 1 indexed citations
12.
Nasi, Sonia, Jessica Bertrand, Miriam Bollmann, Richard Stange, & Thomas Pap. (2020). THU0435 CALCIUM PYROPHOSPHATE DIHYDRATE (CPPD) CRYSTALS BUT NOT BASIC CALCIUM PHOSPHATE (BCP) CRYSTALS INDUCE SYNDECAN-4 EXPRESSION IN CARTILAGE. Annals of the Rheumatic Diseases. 79. 454–455. 2 indexed citations
13.
Bollmann, Miriam, Thomas Pap, Christoph H. Lohmann, & Jessica Bertrand. (2019). Matrix metalloproteinase mediated shedding of Syndecan-4 under osteoarthritis conditions. Osteoarthritis and Cartilage. 27. S196–S197. 1 indexed citations
14.
Bollmann, Miriam, Ulrich Hansen, Thomas Pap, et al.. (2019). Inhibition of SDC4-LOX mediated extracellular matrix stiffening prevents chondrocyte differentiation in OA cartilage via increased YAP/TAZ signaling. Osteoarthritis and Cartilage. 27. S150–S151. 1 indexed citations
15.
Ivanisenko, Nikita V., et al.. (2019). Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes. BMC Genomics. 20(S3). 293–293. 10 indexed citations
16.
Bertrand, Jessica & Miriam Bollmann. (2018). Soluble syndecans: biomarkers for diseases and therapeutic options. British Journal of Pharmacology. 176(1). 67–81. 62 indexed citations
17.
Bollmann, Miriam, et al.. (2018). Inhibition of the complement system component C5 as possible treatment in OA. Osteoarthritis and Cartilage. 26. S108–S108. 2 indexed citations
18.
Glas, Adrian, L. Dietrich, Miriam Bollmann, et al.. (2018). Targeting β-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage. Osteoarthritis and Cartilage. 26(6). 818–823. 36 indexed citations
19.
Bollmann, Miriam, et al.. (2017). Shed syndecan 4 in synovial fluid as a biomarker for OA severity. Osteoarthritis and Cartilage. 25. S93–S94. 1 indexed citations
20.
Gunawan, Bastian, Anja von Heydebreck, Bjoern Sander, et al.. (2007). An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. The Journal of Pathology. 211(4). 463–470. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiro Ogino Breakdown of academic impact, for papers by Guanyu Yu Breakdown of academic impact, for papers by Yong Il Kim Breakdown of academic impact, for papers by Yoshiko Tamai Breakdown of academic impact, for papers by Şirin Başpınar Breakdown of academic impact, for papers by Rabia Islam Breakdown of academic impact, for papers by Mai Iwaya Breakdown of academic impact, for papers by Ryosuke Ikeda Breakdown of academic impact, for papers by Wioleta Marut Breakdown of academic impact, for papers by Emi Nishimagi
Rankless by CCL
2026